Aclaris Therapeutics to Participate in Two June Healthcare Conferences

Rhea-AI Summary

Aclaris Therapeutics (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on immuno-inflammatory diseases, has announced its participation in two major healthcare conferences in June 2025. The company's CEO Dr. Neal Walker and senior leadership team will participate in:

1. A fireside chat at the Jefferies Global Healthcare Conference in New York on June 4, 2025, at 10:30 AM EDT

2. A fireside chat at the 46th Annual Goldman Sachs Global Healthcare Conference in Miami on June 11, 2025, at 1:20 PM EDT

Live webcasts of both events will be available on the Events page of Aclaris' website and will remain accessible for at least 30 days.

WAYNE, Pa., May 28, 2025 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced that the Company will participate in two upcoming healthcare conferences in June.

• On Wednesday June 4, 2025, at 10:30 AM EDT, Aclaris’ Chief Executive Officer Dr. Neal Walker and other members of Aclaris’ senior leadership team will participate in a fireside chat during Jefferies Global Healthcare Conference in New York, NY.
  
  
• On Wednesday June 11, 2025, at 1:20 PM EDT, Dr. Walker and other members of Aclaris’ senior leadership team will participate in a fireside chat during the 46th Annual Goldman Sachs Global Healthcare Conference in Miami, FL.
  

A live and archived webcast of both events will be accessible on the Events page of https://www.aclaristx.com/. The webcasts will be available on the Aclaris website for at least 30 days.

About Aclaris Therapeutics, Inc.

Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of novel product candidates to address the needs of patients with immuno-inflammatory diseases who lack satisfactory treatment options. The company has a multi-stage portfolio of product candidates powered by a robust R&D engine. For additional information, please visit www.aclaristx.com and follow Aclaris on X (formerly Twitter) at @AclarisTx and on LinkedIn.

Aclaris Therapeutics Contact:

Will Roberts
Senior Vice President
Corporate Communications and Investor Relations
(484) 329-2125
wroberts@aclaristx.com

FAQ

What conferences will Aclaris Therapeutics (ACRS) attend in June 2025?

Aclaris Therapeutics will participate in the Jefferies Global Healthcare Conference in New York on June 4 and the 46th Annual Goldman Sachs Global Healthcare Conference in Miami on June 11, 2025.

When is Aclaris Therapeutics (ACRS) presenting at the Jefferies Global Healthcare Conference 2025?

Aclaris Therapeutics will participate in a fireside chat at the Jefferies Global Healthcare Conference on Wednesday, June 4, 2025, at 10:30 AM EDT in New York.

Who will represent Aclaris Therapeutics (ACRS) at the upcoming June 2025 healthcare conferences?

CEO Dr. Neal Walker and other members of Aclaris' senior leadership team will represent the company at both conferences.

How can investors access Aclaris Therapeutics' (ACRS) conference presentations in June 2025?

Live and archived webcasts of both presentations will be available on the Events page of Aclaris' website (aclaristx.com) and will remain accessible for at least 30 days.